<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Composite graft replacement of the ascending aorta and aortic valve was performed in 78 patients over an 8 1/2-year period </plain></SENT>
<SENT sid="1" pm="."><plain>Degenerative lesions of the aortic root in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> (annuloaortic <z:mpath ids='MPATH_474'>ectasia</z:mpath>) was the indication for operation in 56 cases; the other 22 patients had other causes of <z:hpo ids='HP_0002616'>aortic root dilatation</z:hpo> and <z:e sem="disease" ids="C1260873" disease_type="Disease or Syndrome" abbrv="">aortic valve disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Overall hospital mortality was 8% </plain></SENT>
<SENT sid="3" pm="."><plain>Follow-up ranged from 1-9 years (average 5 years) </plain></SENT>
<SENT sid="4" pm="."><plain>Reoperation was required in six of the 72 hospital survivors </plain></SENT>
<SENT sid="5" pm="."><plain>Overall 5-year actuarial survival was 77%, and 85% of the survivors have shown significant clinical and radiologic improvement </plain></SENT>
<SENT sid="6" pm="."><plain>Composite graft replacement reduces the risk of <z:hpo ids='HP_0002617'>aneurysm</z:hpo> formation of the sinuses of Valsalva and eliminates paraprosthetic leakage; postoperative <z:mp ids='MP_0001914'>hemorrhage</z:mp> is also reduced </plain></SENT>
<SENT sid="7" pm="."><plain>It appears to be the method of choice for patients with degenerative lesions in the ascending aorta and valve, particularly annuloaortic <z:mpath ids='MPATH_474'>ectasia</z:mpath> </plain></SENT>
</text></document>